Janku, Filip
Yap, Timothy A.
Meric-Bernstam, Funda
Article History
First Online: 6 March 2018
Competing interests
: F.J. has received research support from Genentech, Novartis, and Piqur and has served on scientific advisory boards for Novartis. T.A.Y. has been a member of the scientific advisory boards of AstraZeneca, Bristol-Myers Squibb, Clovis Oncology, EMD Serono, Ignyta, and Pfizer, has received research funding from AstraZeneca, Clearbridge BioMedics, and Vertex, and has received travel support from AstraZeneca, Bristol-Myers Squibb, EMD Serono, Janssen-Cilag, MSD Oncology, and Vertex. F.M.-B. has received research funding from Aileron, AstraZeneca, Bayer, Calithera, Curis, CytomX, Debiopharm, Effective Pharmaceuticals, Genentech, Jounce, Novartis, Pfizer, PUMA, Taiho, and Zymeworks and has served on advisory boards for ClearLight Diagnostics, Darwin Health, GRAIL, and Pieris.